CONTACT INFORMATIONBIOGRAPHYCREDENTIALSPUBLICATIONSJohn D. Lueck, Ph.D.Contact InformationPhone NumbersOffice: (585) 276-5489Fax: (585) 273-2652Research LabsVisit Lab WebsiteLocationsUniversity of Rochester Medical CenterSchool of Medicine and Dentistry601 Elmwood Ave, Box 711Rochester, NY 14642Additional LinksCenter for RNA BiologyFaculty AppointmentsAssistant Professor - Department of Pharmacology and Physiology (SMD) Assistant Professor - Department of Neurology , NMD (SMD) - JointBiographyProfessional BackgroundThe focus of my research is to evaluate the therapeutic promise of suppressor tRNA for treatment of cystic fibrosis. In my graduate training I studied myotonia in myotonic dystrophy type 1 (DM1) in Dr. Robert Dirksen’s laboratory and in collaboration with Dr. Charles Thornton. I used both molecular biology/genetics and electrophysiology approaches to determine how the DM1-associated problems with alternative splicing affect function of ClC-1 chloride channel and muscle excitability. I showed that chloride conductance is rapidly rescued if ClC-1 splicing is corrected or if sequestration of splicing factors is released. I also investigated the effects of splicing misregulation on function of RyR1. These studies resulted in 10 publications and cemented my interest in doing translational research. Following my graduate work, I joined Dr. Kevin Campbell’s laboratory. There I learned membrane protein biochemistry, antibody generation and testing mouse skeletal muscle physiology testing and gene therapy approaches, in studies focused on muscular dystrophy. This experience makes me well suited to conduct independent research using a breadth of techniques focused disease pathogenesis. My research took a turn as I became interested in the field of genetic code expansion and its use as a therapeutic for cystic fibrosis (CF) that result from nonsense mutations. I quickly published 5 studies in 3 years with Dr. Chris Ahern that propelled me to my current independent position, where I have been able to extend my research in determining the therapeutic promise of our suppressor tRNA technologies for CF. In my next steps, I will use my extensive training in mouse genetics, molecular biology, membrane biophysics and protein biochemistry to investigate the impact on cellular and tissue processes following stop codon suppression in vivo and generate new CF therapeutic deliverables that can be translated into other nonsense associated diseases. More broadly, I'm interested in applying membrane biophysics and molecular and cellular biology approaches to elucidate the molecular underpinning of genetic diseases, and then using mechanistic insights to develop new treatments.ResearchMy research focuses on the molecular genetics and experimental treatment of diseases resulting from nonsense mutations. I am investigating the use of engineered tRNAs for suppression of nonsense mutations in cystic fibrosis transmembrane conductance regulator (CFTR) transcripts as therapeutic intervention for cystic fibrosis. Additionally, I am interested in the molecular genetics and experimental treatment of the trinucleotide repeat disorder myotonic dystrophy (DM1). Moving forward, I intend to study pre-mRNA splicing defects in DM1 to determine the causes of muscle weakness and wasting, and develop and test new therapeutic strategies to target the genetic misstep and reverse symptoms. More broadly, I'm interested in applying membrane biophysics, molecular and cellular biology approaches to understand the molecular underpinning of genetic diseases and develop therapeutic interventions.PublicationsJournal Articles1/17/2023Allaire NE, Griesenbach U, Kerem B, Lueck JD, Stanleigh N, Oren YS. "Gene, RNA, and ASO-based therapeutic approaches in Cystic Fibrosis." Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.. 2023 Jan 17; Epub 2023 Jan 17. 6/14/2022Ko W, Porter JJ, Sipple MT, Edwards KM, Lueck JD. "Efficient suppression of endogenous CFTR nonsense mutations using anticodon-engineered transfer RNAs." Molecular therapy. Nucleic acids.. 2022 Jun 14; 28:685-701. Epub 2022 May 04. 2/10/2021Porter JJ, Heil CS, Lueck JD. "Therapeutic promise of engineered nonsense suppressor tRNAs." Wiley interdisciplinary reviews. RNA.. 2021 Feb 10; :e1641. Epub 2021 Feb 10. VIEW ALL PUBLICATIONSClose WindowSchedule an appointment with John D. Lueck, Ph.D.Please answer the following questions to help us find the right appointment for you.Important: If you believe that you have a medical or psychiatric emergency, please call 911 or go to the nearest hospital. This website is not intended for emergency care.Have you seen this provider in the last 2 years?YesNoExisting Patient Schedule or request a follow up appointment online through MyChart. If you do not have a MyChart account, please close this window and call the appointment phone number. John D. Lueck, Ph.D. is currently scheduling for the following appointment type(s): Our policy does not permit patients to establish care with multiple providers within the same practice or specialty without prior approval. If you choose a new provider in the same office, we will cancel the appointment. Please contact the office directly with questions on this policy.